Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 3 | 3 | 19 | 19 |
| Average estimate | 11.16 | 15.25 | 48.63 | 59.53 |
| Low estimate | 8.26 | 9.20 | 47.30 | 55.90 |
| High estimate | 12.76 | 22.73 | 53.12 | 66.93 |
| Last year EPS | 11.10 | 8.45 | 44.87 | 48.63 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 2 | 2 | 17 | 19 |
| Avg. estimate | 187.69B | 176.46B | 695.21B | 822.36B |
| Low estimate | 187.28B | 175.52B | 686.14B | 789.31B |
| High estimate | 188.10B | 177.40B | 708.00B | 864.60B |
| Last year sales | 159.73B | 148.72B | 577.90B | 674.18B |
| Sales growth | 0.18 | 0.19 | 0.20 | 0.22 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 11.16 | 15.25 | 48.63 | 59.53 |
| 7 days ago | 11.11 | 15.28 | 50.69 | 61.98 |
| 30 days ago | 11.11 | 15.92 | 50.58 | 61.93 |
| 60 days ago | 11.11 | 15.92 | 50.58 | 61.93 |
| 90 days ago | 11.24 | 15.98 | 51.01 | 62.40 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 1 | 2 | 0 | 2 |
| Up last 30 days | 1 | 1 | 0 | 2 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 0 | 1 | 17 | 13 |
| Growth estimates | |
|---|---|
| Current qtr (Oct 2025) | 0.005% |
| Next qtr. (Jan 2026) | 0.805% |
| Current year (2025) | 0.084% |
| Next 5 years (per annum) | 0.507% |
| Past 5 years (per annum) | 0.720% |